Seeking Alpha

Theravance (THRX +4.8%) draws some notice from investors after Sanford Bernstein initiates...

Theravance (THRX +4.8%) draws some notice from investors after Sanford Bernstein initiates coverage with an Outperform rating on shares. According to a SEC filing, the biopharmaceutical company also saw some insider buying recently.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector